BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28292277)

  • 1. Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country.
    Jambaldorj E; Han M; Jeong JC; Koo TY; Min SI; Song EY; Ha J; Ahn C; Yang J
    BMC Nephrol; 2017 Mar; 18(1):88. PubMed ID: 28292277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of QuantiFERON-TB assay for prediction of tuberculosis development in kidney transplant patients in an intermediate-tuberculosis-burden country: lack of evidence for enhanced prediction for short-term tuberculosis development.
    Jeong JC; Koo TY; Jeon HJ; Park HC; Ryu HJ; Lee JP; Min SI; Hwang YH; Ha J; Ahn C; Yang J
    Transplant Proc; 2014; 46(2):583-7. PubMed ID: 24656018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
    Edathodu J; Varghese B; Alrajhi AA; Shoukri M; Nazmi A; Elgamal H; Aleid H; Alrabiah F; Ashraff A; Mahmoud I; Al-Hajoj S
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28170135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
    Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living donor and recipient screening for latent tuberculosis infection by tuberculin skin test and interferon-gamma releasing assay in a country with an intermediate burden of tuberculosis.
    Moon SM; Park IA; Kim SM; Park SJ; Jung JH; Kim YH; Park JB; Hong B; Lee SO; Choi SH; Kim YS; Woo JH; Park SK; Lee SK; Park JS; Han DJ; Kim SH
    J Infect Chemother; 2013 Oct; 19(5):1009-13. PubMed ID: 23917533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
    Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients.
    Lee YM; Lee SO; Choi SH; Kim YS; Woo JH; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    J Infect; 2014 Aug; 69(2):165-73. PubMed ID: 24647146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent tuberculosis screening before kidney transplantation in the South of Brazil.
    Meinerz G; Silva CKD; Dorsdt DMB; Adames JB; Andrade JP; Ventura PE; Monteiro AA; Pasqualotto AC; Garcia VD; Keitel E
    J Bras Nefrol; 2021; 43(4):520-529. PubMed ID: 33999988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the tuberculin skin test and interferon-γ release assay for the diagnosis of latent tuberculosis infection before kidney transplantation.
    Kim SY; Jung GS; Kim SK; Chang J; Kim MS; Kim YS; Kang YA; Joo DJ
    Infection; 2013 Feb; 41(1):103-10. PubMed ID: 22802098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
    Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K
    J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidates.
    Mardani M; Farshidpour M; Nekoonam M; Varahram F; Najafizadeh K; Mohammadi N; Sharifkashani B; Gachkar L; Farokhzad B; Droudinia A; Javanmard P; Tabarsi P
    Exp Clin Transplant; 2014 Apr; 12(2):129-32. PubMed ID: 24702145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the QuantiFERON?-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand.
    Reechaipichitkul W; Pimrin W; Bourpoern J; Prompinij S; Faksri K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):236-44. PubMed ID: 26342121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB.
    Ahmadinejad Z; Azmoudeh Ardalan F; Razzaqi M; Davoudi S; Jafarian A
    Transpl Infect Dis; 2013 Feb; 15(1):90-5. PubMed ID: 23173720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of latent tuberculosis infection with short-course regimens in potential living kidney donors.
    Simkins J; Donato-Santana C; Morris MI; Abbo LM; Camargo JF; Anjan S; Natori Y; Guerra G
    Transpl Infect Dis; 2020 Apr; 22(2):e13244. PubMed ID: 31923346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of interferon-γ release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation.
    Ishikawa S; Igari H; Akutsu N; Tsuyuzaki M; Aoyama H; Hasegawa M; Otsuki K; Maruyama M; Saigo K; Suzuki K; Yamagishi F
    J Infect Chemother; 2017 Jul; 23(7):468-473. PubMed ID: 28438462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.